CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 4 Gift 10% owner gave 40,000 shares (gift)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Operating Officer sold 44 shares at $4.87 ($214)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change
- 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 9,645 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Science Officer gave up 19,505 shares (to pay taxes)
- 4/A Shares withheld for taxes President and CEO gave up 56,824 shares (to pay taxes)
- 4/A Shares withheld for taxes SVP, Operations gave up 14,120 shares (to pay taxes)
Page 9 of 35 · 690 filings